Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer
What is Cyfra 21-1 quantification? | Vinmec
PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar
Tumorski markeri: Ako su povišeni, znači li to da je u pitanju rak? - Ordinacija.hr
Klinicka | PDF
Tumor markeri - Rano otkrivanje ključ je uspešnog lečenja || DR Nestorov
CYFRA21-1 tests in the diagnosis of non-small cell lung cancer: A meta-analysis - Lei Fu, Rong Wang, Ling Yin, Xiaopu Shang, Runtong Zhang, Pengjun Zhang, 2019
PDF) Lung Cancer - Clinical Implications
Poliklinika BIOS LAB - Tumorski markeri su materije koje ćelije tumora direktno stvaraju ili podstiču njihovo lučenje iz netumorskih tkiva odnosno ćelija. Prema prisutnosti tumorskih markera i prema njihovoj vrednosti u telesnim
Serum CYFRA 21-1 in Egyptian women with breast cancer - ScienceDirect
Kako Primjenjivati Tumorske Biljege u Kliničkoj Praksi
Elecsys CYFRA 21-1
Kako Primjenjivati Tumorske Biljege u Kliničkoj Praksi
Elecsys CYFRA 21-1
What is Cyfra 21-1 quantification? | Vinmec
PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar
Role of serum CYFRA 21-1 | CMAR
CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy | Anticancer Research
Simple diagnosis of cancer by detecting CEA and CYFRA 21-1 in saliva using electronic sensors | Scientific Reports
PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar
CYFRA21-1 tests in the diagnosis of non-small cell lung cancer: A meta-analysis - Lei Fu, Rong Wang, Ling Yin, Xiaopu Shang, Runtong Zhang, Pengjun Zhang, 2019